Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Delix Therapeutics
Recent news which mentions Delix Therapeutics
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
Tags
Market News
Psilocybin
Psilera
From
Benzinga
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
June 20, 2023
Tags
Markets
Non/Hallucinogenic Psychedelic Compound
Management
From
Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
Benzinga
Psychoplastogens
Next/Generation Psychedelics
From
Benzinga
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
February 17, 2023
Tags
Psychoplastogens
Benzinga
Delix Therapeutics
From
Benzinga
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
February 16, 2023
Tickers
PSYCF
Tags
Next/Generation Psychedelics
Cannabis
Startups
From
Benzinga
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
September 14, 2022
Tickers
DMTTF
NUMIF
TRYPF
Tags
John Nesbett
Nature Biotechnology
Cannabis
From
Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
Tickers
ATAI
AWKNF
CYBN
FTRP
Tags
Small Cap
AWKNF
KONEF
From
Benzinga
Delix Therapeutics Raises $30M In Convertible Note Financing, Will Enhance Drug Development Program
January 11, 2022
Tags
Delix Therapeutics
Cannabis
Benzinga
From
Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
Government
addiction
Cannabis
From
Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
Tickers
BRAXF
FTRP
MCURF
NVMDF
Tags
Cannabis
FTRP
PHRRF
From
Benzinga
'Psychedelics Without Hallucinations': Concept Get Closer To Human Trials With $70M Funding
September 27, 2021
Tags
Markets
Delix Therapeutics
David Olson
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.